- Home
- KNOP vs TRDA Comparison
KNOP vs TRDA Comparison
Compare KNOP & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNOP
- TRDA
- Stock Information
- Founded
- KNOP 2013
- TRDA 2016
- Country
- KNOP United Kingdom
- TRDA United States
- Employees
- KNOP N/A
- TRDA N/A
- Industry
- KNOP Marine Transportation
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- KNOP Consumer Discretionary
- TRDA Health Care
- Exchange
- KNOP Nasdaq
- TRDA Nasdaq
- Market Cap
- KNOP 254.2M
- TRDA 301.0M
- IPO Year
- KNOP 2013
- TRDA 2021
- Fundamental
- Price
- KNOP $6.64
- TRDA $7.12
- Analyst Decision
- KNOP
- TRDA Strong Buy
- Analyst Count
- KNOP 0
- TRDA 3
- Target Price
- KNOP N/A
- TRDA $25.67
- AVG Volume (30 Days)
- KNOP 52.6K
- TRDA 129.9K
- Earning Date
- KNOP 05-20-2025
- TRDA 08-12-2025
- Dividend Yield
- KNOP 1.57%
- TRDA N/A
- EPS Growth
- KNOP N/A
- TRDA N/A
- EPS
- KNOP 0.19
- TRDA 0.61
- Revenue
- KNOP $320,026,000.00
- TRDA $172,220,000.00
- Revenue This Year
- KNOP $6.77
- TRDA N/A
- Revenue Next Year
- KNOP $0.81
- TRDA N/A
- P/E Ratio
- KNOP $35.22
- TRDA $11.74
- Revenue Growth
- KNOP 8.76
- TRDA 5.74
- 52 Week Low
- KNOP $5.28
- TRDA $6.94
- 52 Week High
- KNOP $9.11
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- KNOP 53.46
- TRDA 36.18
- Support Level
- KNOP $6.29
- TRDA $6.94
- Resistance Level
- KNOP $7.01
- TRDA $8.49
- Average True Range (ATR)
- KNOP 0.22
- TRDA 0.42
- MACD
- KNOP 0.03
- TRDA -0.07
- Stochastic Oscillator
- KNOP 49.32
- TRDA 10.91
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.